Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 549

Showing 1-25 of 549 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 205
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Delphine Planas, Isabelle Staropoli, Vincent Michel, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 128
Neutralization, effector function and immune imprinting of Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
Nature (2023) Vol. 621, Iss. 7979, pp. 592-601
Open Access | Times Cited: 117
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation
Da‐Yuan Chen, Chue Vin Chin, Devin Kenney, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 143-150
Open Access | Times Cited: 99
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Felicity Liew, Shubha Talwar, Andy Cross, et al.
EBioMedicine (2022) Vol. 87, pp. 104402-104402
Open Access | Times Cited: 90
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
Naoko Iwata‐Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 83
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 991-991
Open Access | Times Cited: 80
ACE2-Independent Alternative Receptors for SARS-CoV-2
Suhyeon Lim, Monica Zhang, Theresa L. Chang
Viruses (2022) Vol. 14, Iss. 11, pp. 2535-2535
Open Access | Times Cited: 72
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
Christin Mache, Jessica Schulze, Gudrun Holland, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 70
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 51
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants
Cun Li, Jingjing Huang, Yifei Yu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 17
Open Access | Times Cited: 47
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
Taha Y. Taha, Irene P. Chen, Jennifer M. Hayashi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
Yanping Hu, Jing Zou, Chaitanya Kurhade, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 46
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
Kristin Metzdorf, Henning Jacobsen, Marina C. Greweling‐Pils, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 271-271
Open Access | Times Cited: 45
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 45
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
EBioMedicine (2023) Vol. 90, pp. 104545-104545
Open Access | Times Cited: 44
Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1
Joseph L.-H. Tsui, John T. McCrone, Ben Lambert, et al.
Science (2023) Vol. 381, Iss. 6655, pp. 336-343
Open Access | Times Cited: 42
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 24
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating
Nikhila S. Tanneti, Anant K. Patel, Li Tan, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 20
Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19
Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Med (2024) Vol. 5, Iss. 1, pp. 42-61.e23
Open Access | Times Cited: 19
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
Guoli Shi, Tiansheng Li, Kin Kui Lai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
Mengfei Chen, Andrew Pekosz, Jason Villano, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top